Showing results (31-40 of 124) with videos related to

Sort By:
Pageof 13
Chemmedchem|August 1, 2020
Glycoconjugated Metal Complexes as Cancer Diagnostic and Therapeutic AgentsGiulia Bononi, Dalila Iacopini, Gaspare Cicio, et al.
Journal of Natural Products|July 11, 2017
Constituents of Polygala flavescens ssp. flavescens and Their Activity as Inhibitors of Human Lactate DehydrogenaseMarinella De Leo, Lorenzo Peruzzi, Carlotta Granchi, et al.
Nucleosides, Nucleotides & Nucleic Acids|December 2, 2016
A specific inhibitor of lactate dehydrogenase overcame the resistance toward gemcitabine in hypoxic mesothelioma cells, and modulated the expression of the human equilibrative transporter-1Elisa Giovannetti, Leticia G Leon, Valentina E Gómez, et al.
Journal of Medicinal Chemistry|December 22, 2006
New benzopyran-based openers of the mitochondrial ATP-sensitive potassium channel with potent anti-ischemic propertiesMaria C Breschi, Vincenzo Calderone, Alma Martelli, et al.
Nucleosides, Nucleotides & Nucleic Acids|June 20, 2024
Evaluation of the combination of gemcitabine, carboplatin, and lactate dehydrogenase A inhibitor on malignant mesotheliomaMarika A Frańczak, Federica Borea, Ryszard T Smoleński, et al.
Bioorganic & Medicinal Chemistry|September 29, 2012
Salicylaldoxime derivatives as new leads for the development of carbonic anhydrase inhibitorsTiziano Tuccinardi, Simone Bertini, Carlotta Granchi, et al.
Journal of Medicinal Chemistry|October 29, 2004
NO-sartans: a new class of pharmacodynamic hybrids as cardiovascular drugsMaria C Breschi, Vincenzo Calderone, Maria Digiacomo, et al.
Phytochemistry|April 20, 2015
Phenylpropanoids and flavonoids from Phlomis kurdica as inhibitors of human lactate dehydrogenaseAmmar Bader, Tiziano Tuccinardi, Carlotta Granchi, et al.
Organic & Biomolecular Chemistry|August 30, 2013
Assessing the differential action on cancer cells of LDH-A inhibitors based on the N-hydroxyindole-2-carboxylate (NHI) and malonic (Mal) scaffoldsCarlotta Granchi, Emilia C Calvaresi, Tiziano Tuccinardi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|September 23, 2017
Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitorsCarlotta Granchi, Isabella Caligiuri, Eleonora Bertelli, et al.
Pageof 13